mpox Archives - LifeScienceHistory.com

Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication

Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine

Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication

On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…

Global strategic preparedness and response plan launched by WHO to contain mpox outbreak

Biotechnology | Disease | Life Science News | Therapeutics | Vaccine | WHO

Global strategic preparedness and response plan launched by WHO to contain mpox outbreak

On Aug. 26, 2024, the World Health Organization (WHO) launched a global Strategic Preparedness and Response Plan to…

ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely

Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine

ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely

ON Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) reported that it is highly…

WHO declared mpox outbreak a public health emergency of international concern

Biotechnology | Disease | Life Science News | Medicine | Vaccine | WHO

WHO declared mpox outbreak a public health emergency of international concern

On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…

NIH scientists develop mouse model to study Mpox virulence

Life Science News | NIH | Vaccine

NIH scientists develop mouse model to study Mpox virulence

On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…